Learning objectives: Understand the epidemiology, pathology and diagnosis of CMV in the immune comprised and immunocompetent patient.

Understand the new therapeutic agents including pharmacologics and biologics for the treatment of CMV infection and disease.

Session date: 
05/07/2019 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kathleen M. Mullane, DO, Pharm D, FIDSA